Global Gynecology Partnering 2010-2022: Deal trends, players and financials

Publisher Name :
Date: 01-Dec-2022
No. of pages: 300
Inquire Before Buying

Global Gynecology Partnering 2010-2022: Deal trends, players and financials provides the full collection of gynecology disease deals signed between the world's pharmaceutical and biotechnology companies since 2010.

Trends in gynecology partnering deals

Financial deal terms for headline, upfront and royalty by stage of development

Gynecology partnering agreement structure

Gynecology partnering contract documents

Top gynecology deals by value

Most active gynecology dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive gynecology disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering gynecology deals.

The report presents financial deal terms values for gynecology deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of gynecology dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in gynecology dealmaking since 2010 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading gynecology deals since 2010. Deals are listed by headline value. The chapter includes the top 25 most active gynecology dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to gynecology deals since 2010 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all gynecology partnering deals by specific gynecology target announced since 2010. The chapter is organized by specific gynecology therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all gynecology partnering deals signed and announced since 2010. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in gynecology partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of gynecology technologies and products.

Report scope

Global Gynecology Partnering 2010 to 2022 is intended to provide the reader with an in-depth understanding and access to gynecology trends and structure of deals entered into by leading companies worldwide.

Global Gynecology Partnering 2010 to 2022 includes:

Trends in gynecology dealmaking in the biopharma industry since 2010

Access to headline, upfront, milestone and royalty data

Access to hundreds of gynecology deal contract documents

Comprehensive access to over 490 gynecology deal records

The leading gynecology deals by value since 2010

Most active gynecology dealmakers since 2010

The report includes deals for the following indications: Adenomyosis, Cervical Intraepithelial Neoplasia (CIN), Endometriosis, Fibroids, Human papillomavirus (HPV), Infertility, Menopause, Ovarian failure, Pelvic inflammatory disease, Polycystic ovary syndrome, Pre-menstrual syndrome, Prolapse, Amenorrhea, Dysmenorrhea, Pelvic pai, Vaginitis, plus other gynecological indications.

In Global Gynecology Partnering 2010 to 2022, available deals and contracts are listed by:

Headline value

Upfront payment value

Royalty rate value

Stage of development at signing

Deal component type

Technology type

Specific therapy indication

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Gynecology Partnering 2010-2022 report provides comprehensive access to available deals and contract documents for over 490 gynecology deals. Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?

What is actually granted by the agreement to the partner company?

What exclusivity is granted?

What is the payment structure for the deal?

How are the sales and payments audited?

What is the deal term?

How are the key terms of the agreement defined?

How are IPRs handled and owned?

Who is responsible for commercialization?

Who is responsible for development, supply, and manufacture?

How is confidentiality and publication managed?

How are disputes to be resolved?

Under what conditions can the deal be terminated?

What happens when there is a change of ownership?

What sublicensing and subcontracting provisions have been agreed?

Which boilerplate clauses does the company insist upon?

Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?

Which jurisdiction does the company insist upon for agreement law?

Global Gynecology Partnering 2010-2022: Deal trends, players and financials

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in gynecology dealmaking
2.1. Introduction
2.2. Gynecology partnering over the years
2.3. Gynecology partnering by deal type
2.4. Gynecology partnering by industry sector
2.5. Gynecology partnering by stage of development
2.6. Gynecology partnering by technology type
2.7. Gynecology partnering by therapeutic indication

Chapter 3 -Financial deal terms for gynecology partnering
3.1. Introduction
3.2. Disclosed financials terms for gynecology partnering
3.3. Gynecology partnering headline values
3.4. Gynecology deal upfront payments
3.5. Gynecology deal milestone payments
3.6. Gynecology royalty rates

Chapter 4 - Leading gynecology deals and dealmakers
4.1. Introduction
4.2. Most active in gynecology partnering
4.3. List of most active dealmakers in gynecology
4.4. Top gynecology deals by value

Chapter 5 - Gynecology contract document directory
5.1. Introduction
5.2. Gynecology partnering deals where contract document available

Chapter 6 - Gynecology dealmaking by therapeutic target
6.1. Introduction
6.2. Deals by gynecology therapeutic target
Appendices
Appendix 1 - Directory of gynecology deals by company A-Z 2010 to 2022
Appendix 2 - Directory of gynecology deals by deal type 2010 to 2022
Appendix 3 - Directory of gynecology deals by stage of development 2010 to 2022
Appendix 4 - Directory of gynecology deals by technology type 2010 to 2022
Further reading on dealmaking
Deal type definitions
About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from CurrentPartnering

List of Table of Figures

Figure 1: Gynecology partnering since 2010
Figure 2: Gynecology partnering by deal type since 2010
Figure 3: Gynecology partnering by industry sector since 2010
Figure 4: Gynecology partnering by stage of development since 2010
Figure 5: Gynecology partnering by technology type since 2010
Figure 6: Gynecology partnering by indication since 2010
Figure 7: Gynecology deals with a headline value
Figure 8: Gynecology deals with upfront payment values
Figure 9: Gynecology deals with milestone payment
Figure 10: Gynecology deals with royalty rates
Figure 11: Active gynecology dealmaking activity- 2010 to 2022
Figure 12: Top gynecology deals by value since 2010
  • Global Animal Auto-Immune Disease Diagnostics Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 86
    Highlights The global Animal Auto-Immune Disease Diagnostics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. North American market for Animal Auto-Immune Disease Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecas......
  • Global Angiographic Catheters Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 95
    Highlights The global Angiographic Catheters market was valued at US$ 1282.9 million in 2022 and is anticipated to reach US$ 1869.7 million by 2029, witnessing a CAGR of 5.4% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Angiographic Catheters is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period o......
  • Global African Horse Sickness Treatment Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 60
    Highlights The global African Horse Sickness Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. North American market for African Horse Sickness Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of ......
  • Global Aflatoxicosis Treatment Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 85
    Highlights The global Aflatoxicosis Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. North American market for Aflatoxicosis Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.......
  • Global Advanced Infusion Systems Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 85
    Highlights The global Advanced Infusion Systems market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. North American market for Advanced Infusion Systems is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2......
  • Global Addison Disease Testing Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 91
    Highlights The global Addison Disease Testing market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. North American market for Addison Disease Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.......
  • Global Children Emergency Cervical Collars Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 97
    Highlights The global Children Emergency Cervical Collars market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Children Emergency Cervical Collars is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast......
  • Global Adult Emergency Cervical Collars Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 91
    Highlights The global Adult Emergency Cervical Collars market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Adult Emergency Cervical Collars is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast perio......
  • Global Rigid Emergency Cervical Collars Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 91
    Highlights The global Rigid Emergency Cervical Collars market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Rigid Emergency Cervical Collars is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast perio......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs